Alpa Laboratories Ltd

NSE :ALPA BSE :532878 Sector : Pharmaceuticals

Buy, Sell or Hold ALPA? Ask The Analyst

BSE

prev close

OPEN PRICE

bid price (qty)

offer price (qty)

volume

Today's low / high

52 WK low / high

NSE

prev close

open price

bid price (qty)

offer price (qty)

volume

Today's' low / high

52 WK low / high

26 Apr
96.50
(-0.10%)

25 Apr
96.60
(0.84%)

24 Apr
95.80
(1.05%)

23 Apr
94.80
(1.66%)

22 Apr
93.25
(1.25%)

19 Apr
92.10
(2.68%)

18 Apr
89.70
(-0.72%)

16 Apr
90.35
(0.78%)

15 Apr
89.65
(-3.71%)

12 Apr
93.10
(0.05%)

10 Apr
93.05
(0.70%)

09 Apr
92.40
(-1.02%)

08 Apr
93.35
(-2.30%)

05 Apr
95.55
(0.79%)

04 Apr
94.80
(1.28%)

03 Apr
93.60
(0.11%)

02 Apr
93.50
(3.37%)

01 Apr
90.45
(8.65%)

28 Mar
83.25
(-1.07%)

27 Mar
84.15
(-1.58%)

26 Mar
85.50
(-2.68%)

Price Chart Historical Data Technical Chart

Technical Analysis

Short Term Investors

Very Bullish

Medium Term Investors

Neutral

Long Term Investors

Very Bullish

Moving Averages

5 DMA

Bullish

95.53

10 DMA

Bullish

93.24

20 DMA

Bullish

92.3

50 DMA

Bullish

94.66

100 DMA

Bearish

99.11

200 DMA

Bullish

88.14

Intraday Support and Resistance
(Based on Pivot Points) |

Updated On Apr 26, 2024 04:00 PM For Next Trading Session

Pivots	Classic	Fibonacci	Camarilla	Woodie	DM
R3	102.14	100.27	97.53	-	-
R2	100.27	98.84	97.19	100.26	-
R1	98.39	97.95	96.84	98.37	99.33
P	96.52	96.52	96.52	96.51	96.99
S1	94.64	95.09	96.16	94.62	95.58
S2	92.77	94.2	95.81	92.76	-
S3	90.89	92.77	95.47	-	-

Key Metrics

EPS

8.5

P/E

11.41

P/B

1.33

Dividend Yield

0%

Market Cap

203 Cr.

Face Value

10

Book Value

72.87

ROE

7.76%

EBITDA Growth

4.98 Cr.

Debt/Equity

0.03 Shareholding Pattern

	57.29%	Total Promoter Holding

	0%	Mutual Fund Holdings

	0.5%	FIIs

	42.2%	Non Institution

	0%	Insurance Companies

	0%	Custodians

	0.01%	Other Parties

Shareholding History

Alpa Laboratories Ltd Quaterly Results

	Dec 2022	Mar 2023	Jun 2023	Sep 2023	Dec 2023
INCOME	29.98	28.47	29.9	35.35	30.86
PROFIT	5.12	4.65	3	5.79	4.5
EPS	2.43	2.12	1.44	2.75	2.17

Alpa Laboratories Ltd Quaterly Results

	Dec 2022	Mar 2023	Jun 2023	Sep 2023	Dec 2023
INCOME	30.01	28.4	29.9	35.35	30.86
PROFIT	5.14	4.62	3	5.74	4.51
EPS	2.45	2.09	1.44	2.75	2.15

Profit & Loss (Figures in Rs. Crores)

Consolidated
Standalone

Alpa Laboratories Ltd Profit & Loss

	Mar 2014	Mar 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023
INCOME	58.16	59.26	62.75	68.06	67.4	81.76	89.3	103.1	122.52	101.06
PROFIT	-5.15	-0.25	6.85	3.19	2.92	0.87	2.64	5.19	7.72	9.95
EPS	0	0	3.25	1.2	1.33	0.48	0.88	3.44	6.7	5.98

Alpa Laboratories Ltd Profit & Loss

	Mar 2014	Mar 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023
INCOME	58.16	58.11	63.57	69.44	66.68	81.53	89.36	103.11	122.53	101.1
PROFIT	-5.15	-0.25	7.74	6.95	4.9	2.67	5.39	5.16	7.75	10.03
EPS	0	0	3.68	2.85	2.26	1.4	1.94	3.45	6.71	6

Balance Sheet (Figures in Rs. Crores)

Consolidated
Standalone

	Mar 2023	Mar 2022	Mar 2021	Mar 2020	Mar 2019	Mar 2018	Mar 2017	Mar 2016	Mar 2015	Mar 2014
SOURCES OF FUNDS :
Share Capital	21.04	21.04	21.04	21.04	21.04	21.04	21.04	21.04	21.04	21.04
Reserves Total	113.54	100.69	86.6	79.33	77.45	76.51	73.69	72.36	65.52	67.27
Total Shareholders Funds	134.58	121.73	107.64	100.37	98.49	97.55	94.73	93.4	86.56	88.31
Secured Loans	0.78	4.47	0.01	0.41	1.67	5.98	10.72	24.23	28.57	22.99
Unsecured Loans	1.53	1.38	0.18	0	0	0	0	0	0	0
Total Debt	2.31	5.85	0.19	0.41	1.67	5.98	10.72	24.23	28.57	22.99
Other Liabilities	0	0	0	0	0	0	0.63	0.6	0.51	0.51
Total Liabilities	136.89	127.58	107.83	100.78	100.16	103.53	106.08	118.23	115.64	111.81
APPLICATION OF FUNDS :
Gross Block	33.46	34.41	30.64	30.01	38.86	38.12	40.34	34.74	24.06	102.01
Less: Accumulated Depreciation	26.42	25.09	23.43	23.61	31.08	27.96	24.9	20.1	19.27	28.9
Net Block	7.04	9.32	7.21	6.4	7.78	10.16	15.44	14.64	4.79	73.11
Capital Work in Progress	0	0	1.58	0.81	0.12	0	0	0	0.07	0
Investments	78.45	74.63	50.84	56.58	48.59	30.56	12.72	12.16	10.1	0
Inventories	12.64	15.46	16.56	12.55	14.04	13.72	13.04	15	7.52	13
Sundry Debtors	46.73	38.04	35.43	24.59	30	26.02	29.16	34.34	24.48	20.08
Cash and Bank Balance	8.81	1.58	10.51	6.17	0.9	21.34	36.68	36.64	72.14	10.46
Loans and Advances	8.91	14.24	17.89	12.86	19.19	18.96	17.83	30.78	8.5	9.21
Total Current Assets	77.1	69.31	80.39	56.17	64.13	80.04	96.71	116.76	112.63	52.76
Current Liabilities	24.42	22.44	30.35	17.59	18.82	16.93	17.93	23.53	11.41	12.78
Provisions	5.97	5.22	1.97	2.97	2.24	1.07	1.53	2.53	1.26	0.74
Total Current Liabilities & Provisions	30.39	27.66	32.32	20.57	21.06	18	19.46	26.06	12.67	13.51
Net Current Assets	46.71	41.65	48.08	35.61	43.07	62.04	77.26	90.7	99.96	39.24
Deferred Tax Assets	0	0	0	0.93	0.17	0.76	0.66	0.05	0.09	0
Deferred Tax Liability	0	0	0.22	0	0	0	0	0	0	1.4
Net Deferred Tax	0	0	-0.22	0.93	0.17	0.76	0.66	0.05	0.09	-1.4
Other Assets	4.67	1.98	0.34	0.45	0.43	0	0	0.69	0.62	0.84
Total Assets	136.87	127.58	107.84	100.79	100.16	103.53	106.08	118.25	115.64	111.79
Contingent Liabilities	3.18	5.21	5.21	5.68	4.07	3.11	2.17	2.58	40.29	1.19

	Mar 2023	Mar 2022	Mar 2021	Mar 2020	Mar 2019	Mar 2018	Mar 2017	Mar 2016	Mar 2015	Mar 2014
SOURCES OF FUNDS :
Share Capital	21.04	21.04	21.04	21.04	21.04	21.04	21.04	21.04	21.04	21.04
Reserves Total	123.49	110.6	96.48	89.19	85.09	82.2	77.42	73.26	65.52	67.27
Total Shareholders Funds	144.53	131.64	117.52	110.23	106.13	103.24	98.46	94.3	86.56	88.31
Secured Loans	1.07	4.47	0.01	0.41	1.67	5.98	10.72	24.23	28.57	22.99
Unsecured Loans	1.53	1.38	0.18	0	0	0	0	0	0	0
Total Debt	2.6	5.85	0.19	0.41	1.67	5.98	10.72	24.23	28.57	22.99
Other Liabilities	0	0	0	0	0	0	0	0.6	0.51	0.51
Total Liabilities	147.13	137.49	117.71	110.64	107.8	109.22	109.18	119.13	115.64	111.81
APPLICATION OF FUNDS :
Gross Block	33.46	34.41	30.64	30.01	28.74	28.01	26.04	24.62	24.06	102.01
Less : Accumulated Depreciation	26.42	25.09	23.43	23.61	22.98	21.89	20.86	20.1	19.27	28.9
Net Block	7.04	9.32	7.21	6.4	5.76	6.12	5.18	4.52	4.79	73.11
Capital Work in Progress	0	0	1.57	0.81	0.12	0	0	0	0.07	0
Investments	89.6	85.73	61.93	67.61	59.43	41.34	23.49	22.13	10.11	0
Inventories	12.64	15.46	16.56	12.55	14.04	13.72	13.04	15	7.52	13
Sundry Debtors	46.73	38.04	35.43	24.59	29.81	25.44	29.16	34.26	24.48	20.08
Cash and Bank Balance	8.79	1.31	10.24	5.92	0.88	21.29	35.53	34.76	72.13	10.46
Loans and Advances	8.02	13.3	16.96	11.94	18.18	17.92	22.02	33.62	8.55	9.21
Total Current Assets	76.19	68.11	79.18	55	62.91	78.36	99.75	117.65	112.67	52.76
Current Liabilities	24.42	22.43	30.34	17.59	18.79	16.3	18.36	23.38	11.41	12.78
Provisions	3.68	2.65	1.96	2.97	2.24	1.07	1.54	2.53	1.26	0.74
Total Current Liabilities & Provisions	28.1	25.08	32.3	20.56	21.03	17.37	19.9	25.91	12.67	13.51
Net Current Assets	48.08	43.03	46.88	34.44	41.89	61	79.85	91.73	100	39.24
Deferred Tax Assets	0	0	0	0.93	0.17	0.76	0.66	0.05	0.09	0
Deferred Tax Liability	2.28	2.57	0.22	0	0	0	0	0	0	1.4
Net Deferred Tax	-2.28	-2.57	-0.22	0.93	0.17	0.76	0.66	0.05	0.09	-1.4
Other Assets	4.67	1.98	0.34	0.45	0.43	0	0	0.69	0.56	0.84
Total Assets	147.11	137.49	117.72	110.65	107.8	109.22	109.18	119.13	115.63	111.79
Contingent Liabilities	3.18	5.21	5.21	5.68	4.07	3.11	2.17	6.47	40.29	1.19

Cash Flow (Figures in Rs. Crores)

Consolidated
Standalone

Cash from Operating Activity 8.9

Net Profit before Tax and Extr...	15.68
Depreciation	1.33
Interest (Net)	-0.82
Dividend Received	0.19
P/L on Sales of Invest	-3.3
Prov. and W/O (Net)	0.6
Total Adjustments (PBT and Ext...	-2.38
Operating Profit before Workin...	13.3
Trade and 0ther Receivables	-6.64
Inventories	2.82
Trade Payables	1.98
Total Adjustments (OP before W...	-0.8
Cash Generated from/(used in) ...	12.5
Direct Taxes Paid	-3.6
Total Adjustments(Cash Generat...	-3.6
Cash Flow before Extraordinary...	8.9
Net Cash from Operating Activi...	8.9

Cash from Investing Activity 2.13

Purchased of Fixed Assets	-1.13
Purchase of Investments	-0.03
Interest Received	1.04
Acquisition of Companies	-0.5
Net Cash used in Investing Act...	2.13

Cash from Financing Activity -3.79

Of the Long Tem Borrowings	-3.57
Interest Paid	-0.22
Net Cash used in Financing Act...	-3.79

Cash from Operating Activity 8.82

Net Profit before Tax and Extr...	15.72
Depreciation	1.33
Interest (Net)	-0.82
Dividend Received	0.19
Prov. and W/O (Net)	0.6
Total Adjustments (PBT and Ext...	-2.44
Operating Profit before Workin...	13.29
Trade and 0ther Receivables	-6.9
Inventories	2.82
Trade Payables	1.98
Total Adjustments (OP before W...	-1.06
Cash Generated from/(used in) ...	12.23
Direct Taxes Paid	-3.41
Total Adjustments(Cash Generat...	-3.41
Cash Flow before Extraordinary...	8.82
Net Cash from Operating Activi...	8.82

Cash from Investing Activity 2.14

Purchased of Fixed Assets	-1.13
Purchase of Investments	-0.46
Interest Received	1.04
Acquisition of Companies	-0.05
Net Cash used in Investing Act...	2.14

Cash from Financing Activity -3.48

Of the Long Tem Borrowings	-3.25
Interest Paid	-0.22
Net Cash used in Financing Act...	-3.48

Company Details

Registered Office
Address	33/2 Pigdamber, A B Road Rau
City	Indore
State	Madhya Pradesh
Pin Code	453446
Tel. No.	91-731-4294567
Fax. No.	91-731-4294444
Email	mail@alpalabs.in
Internet	http://www.alpalabs.in

Registrars
Address	33/2 Pigdamber
City	Indore
State	Madhya Pradesh
Pin Code	453446
Tel. No.	91-731-4294567
Fax. No.	91-731-4294444
Email	mail@alpalabs.in
Internet	http://www.alpalabs.in

Management
Name	Designation
Mahendra Singh Chawla	Chairman & Exec. Director
Pravin C Shah	Executive Director
Sharad Chand Lunawat	Independent Director
Devendra Baheti	Independent Director
Krishna Das Malani	Independent Director
Paresh Chawla	Managing Director
Jyoti Jain	Independent Director
Swati Bagh	Company Sec. & Compli. Officer
Vitthal Kothana	Executive Director
SUNIL VALECHA	Additional Director
Saket Baheti	Independent Director
Pratibha Lunawat	Independent Director

MARKET TODAY

PRODUCTS

SUPPORT

LEGAL & PRIVACY

MAGAZINES

Stocks: A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z

Data is a real-time snapshot *Data is delayed by at least 15 minutes. StockFact, Market Action Data and Analysis. Data Provider CMOTS Infotech.

Disclaimer : There is no guarantee of profits or no exceptions from losses. The investment advice provided is solely the personal views of the research team. Equitypandit will not accept any liability for loss or damage as a result of reliance on the information contained within this website including data, quotes, charts and buy/sell signals. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible. Therefore, Equitypandit doesn't bear any responsibility for any trading losses you might incur as a result of using this data.

Alpa Laboratories Ltd

Buy, Sell or Hold ALPA? Ask The Analyst

BSE

NSE

Price Chart Historical Data Technical Chart

Technical Analysis

Short Term Investors

Very Bullish

Medium Term Investors

Neutral

Long Term Investors

Very Bullish

Moving Averages

5 DMA

Bullish

10 DMA

Bullish

20 DMA

Bullish

50 DMA

Bullish

100 DMA

Bearish

200 DMA

Bullish

Intraday Support and Resistance (Based on Pivot Points) |

Key Metrics

EPS

8.5

P/E

11.41

P/B

1.33

Dividend Yield

0%

Market Cap

203 Cr.

Face Value

10

Book Value

72.87

ROE

7.76%

EBITDA Growth

4.98 Cr.

Debt/Equity

0.03

Shareholding Pattern

Shareholding History

Quarterly Result (Figures in Rs. Crores)

Alpa Laboratories Ltd Quaterly Results

Alpa Laboratories Ltd Quaterly Results

Profit & Loss (Figures in Rs. Crores)

Alpa Laboratories Ltd Profit & Loss

Alpa Laboratories Ltd Profit & Loss

Balance Sheet (Figures in Rs. Crores)

Cash Flow (Figures in Rs. Crores)

Company Details

Registered Office

Registrars

Management

MARKET TODAY

PRODUCTS

SUPPORT

LEGAL & PRIVACY

MAGAZINES

Intraday Support and Resistance
(Based on Pivot Points) |